Last reviewed · How we verify
Continued cotrimoxazole prophylaxis — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Continued cotrimoxazole prophylaxis (Continued cotrimoxazole prophylaxis) — Medical Research Council.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Continued cotrimoxazole prophylaxis TARGET | Continued cotrimoxazole prophylaxis | Medical Research Council | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Continued cotrimoxazole prophylaxis CI watch — RSS
- Continued cotrimoxazole prophylaxis CI watch — Atom
- Continued cotrimoxazole prophylaxis CI watch — JSON
- Continued cotrimoxazole prophylaxis alone — RSS
Cite this brief
Drug Landscape (2026). Continued cotrimoxazole prophylaxis — Competitive Intelligence Brief. https://druglandscape.com/ci/continued-cotrimoxazole-prophylaxis. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing